Research output per year
Research output per year
Personal profile
Headline
ASSISTANT PROFESSOR | Medicine, Hematology and Medical Oncology
Fingerprint
Dive into the research topics where Shyamala Navada is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Ascertaining QUAZARs: slow-motion and light-speed development of oral azacitidine and decitabine
Feld, J., Tremblay, D., Navada, S. C. & Silverman, L. R., 2023, In: Leukemia and Lymphoma. 64, 3, p. 525-539 15 p.Research output: Contribution to journal › Review article › peer-review
-
Immunoglobulin repletion during blinatumomab therapy does not reduce the rate of secondary hypogammaglobulinemia and associated infectious risk
Wo, S., Levavi, H., Mascarenhas, J., Kremyanskaya, M., Navada, S., Bar-Natan, M. & Kim, S. S., 2022, In: Blood Research. 57, 2, p. 135-143 9 p.Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations -
Forsaken Pharmaceutical: Glasdegib in Acute Myeloid Leukemia and Myeloid Diseases
Feld, J., Silverman, L. R. & Navada, S. C., Apr 2021, In: Clinical Lymphoma, Myeloma and Leukemia. 21, 4, p. e415-e422Research output: Contribution to journal › Review article › peer-review
3 Scopus citations -
Safety and Efficacy: Clinical Experience of Venetoclax in Combination with Hypomethylating Agents in Both Newly Diagnosed and Relapsed/Refractory Advanced Myeloid Malignancies
Feld, J., Tremblay, D., Dougherty, M., Czaplinska, T., Sanchez, G., Brady, C., Kremyanskaya, M., Bar-Natan, M., Keyzner, A., Marcellino, B. K., Gabrilove, J., Navada, S. C., Silverman, L. R., El Jamal, S. M., Mascarenhas, J. & Shih, A. H., 9 Apr 2021, In: HemaSphere. 5, 4, e549.Research output: Contribution to journal › Article › peer-review
Open Access20 Scopus citations -
Therapeutics and DNA methylation inhibitors
Navada, S. C., 1 Jan 2021, Medical Epigenetics. Elsevier, p. 585-595 11 p.Research output: Chapter in Book/Report/Conference proceeding › Chapter › peer-review
Press/Media
-
Five Presentations on Rigosertib in Myelodysplastic Syndromes (MDS) at the ASH 2019 Annual Meeting &Exposition
7/11/19
2 items of Media coverage
Press/Media
-
Onconova Announces Five Presentations on Rigosertib in Myelodysplastic Syndromes (MDS) at the ASH 2019 Annual Meeting & Exposition
7/11/19
1 item of Media coverage
Press/Media
-
Onconova Announces Five Presentations on Rigosertib in Myelodysplastic Syndromes (MDS) at the ASH 2019 Annual Meeting & Exposition
7/11/19
2 items of Media coverage
Press/Media
-
Onconova Announces Five Presentations on Rigosertib in Myelodysplastic Syndromes (MDS) at the ASH 2019 Annual Meeting & Exposition
7/11/19
8 items of Media coverage
Press/Media